Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

References

• SchuhmacherCReimDNovotnyANeoadjuvant treatment for gastric cancerJ Gastric Cancer2013132737823844320
   PubMedGoogle Scholar
• SiegelRLMillerKDJemalACancer Statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• MackenzieMSpithoffKJonkerDSystemic therapy for advanced gastric cancer: a clinical practice guidelineCurr Oncol2011184e202e20921874111
   PubMed Web of Science ®Google Scholar
• ManoharanVLeeSChongSSerial imaging using [18F] Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapyAnn Nucl Med201731431532328299585
   PubMed Web of Science ®Google Scholar
• LiSLiBWangJIdentification of sensitivity predictors of neoadjuvant chemotherapy for the treatment of adenocarcinoma of gastroesophageal junctionOncol Res2017251939728081737
   PubMedGoogle Scholar
• Neves FilhoEHde Sant’AnaRONunesLVPiresAPda CunhaMDHistopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical reviewAPMIS20171252798428044374
   PubMed Web of Science ®Google Scholar
• ParkSCChunHJChemotherapy for advanced gastric cancer: review and update of current practicesGut Liver20137438539323898376
   PubMed Web of Science ®Google Scholar
• WangXWangMLZhouLYLuXYYangJFYuHGRandomized phaseII study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancerClin Transl Oncol2013151083684223381898
   PubMedGoogle Scholar
• BangYJKimYWYangHKCLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialLancet2012379981331532122226517
   PubMed Web of Science ®Google Scholar
• QuéroLGuillermSHennequinCNeoadjuvant or adjuvant therapy for gastric cancerWorld J Gastrointest Oncol20157810211026306142
   PubMed Web of Science ®Google Scholar
• PangWLouNJinCCombination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancerEur J Gastroenterol Hepatol201628549350226854795
   PubMed Web of Science ®Google Scholar
• KimKHKwonHCOhSYClinicopathological significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-Fu and cisplatin chemotherapyBiomarkers2011161748221133646
   PubMed Web of Science ®Google Scholar
• ShiraiOOhmiyaNTaguchiAP53, P21 and P73 gene polymorphisms in gastric carcinomaHepatogastroenterology2010571041595160121443127
   PubMedGoogle Scholar
• ColottaFAllavenaPSicaAGarlandaCMantovaniACancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis20093071073108119468060
   PubMed Web of Science ®Google Scholar
• GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
   PubMed Web of Science ®Google Scholar
• BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
   PubMed Web of Science ®Google Scholar
• BorsigLWolfMJRoblekMLorentzenAHeikenwalderMInflammatory chemokines and metastasis-tracing the accessoryOncogene201433253217322423851506
   PubMed Web of Science ®Google Scholar
• FengFSunLZhengGLow lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancerOncotarget2017835281529128029656
   PubMedGoogle Scholar
• LianLXiaYYZhouCApplication of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancerCancer Biomark201515689990726444485
   PubMed Web of Science ®Google Scholar
• WangSCChouJFStrongVEPretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinomaAnn Surg2016263229229725915915
   PubMedGoogle Scholar
• KunisakiCTakahashiMOnoHAInflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and S-1 combination chemotherapyOncology201283418319122890015
   PubMedGoogle Scholar
• GohBKChokAYAllenJCJrBlood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumorsSurgery201615941146115626688506
   PubMed Web of Science ®Google Scholar
• WashingtonK7th edition of the AJCC cancer staging manual: stomachAnn Surg Oncol201017123077307920882416
   PubMed Web of Science ®Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RESIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar
• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• BrenkmanHJHaverkampLRuurdaJPvan HillegersbergRWorldwide practice in gastric cancer surgeryWorld J Gastroenterol201622154041404827099448
   PubMedGoogle Scholar
• DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• KohCHBhoo-PathyNNgKLUtility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerBr J Cancer2015113115015826022929
   PubMed Web of Science ®Google Scholar
• StotzMPichlerMAbsengerGThe preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancerBr J Cancer2014110243544024357796
   PubMed Web of Science ®Google Scholar
• TanogluAKaragozEYiyitNBerberUIs combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma?Onco Targets Ther2014743343424665204
   PubMed Web of Science ®Google Scholar
• GuLMaXLiHPrognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogramSci Rep20166238462385627035802
   PubMedGoogle Scholar
• XiaW-KLiuZ-LShenDLinQ-FSuJMaoW-DPrognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcomaWorld J Surg Oncol20161412713527125872
   PubMed Web of Science ®Google Scholar
• BaganteFTranTBPostlewaitLMNeutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinomaJ Surg Oncol2015112216417226234285
   PubMed Web of Science ®Google Scholar
• LochheadPEl-OmarEMGastric cancerBr Med Bull2008858710018267927
   PubMed Web of Science ®Google Scholar
• KimJHHanDSBangHYKimPSLeeKYPreoperative neutrophil-to-lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancerAnn Surg Treat Res2015892818626236697
   PubMedGoogle Scholar
• el AzizLMBlood neutrophil–lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4Med Oncol2014311231131625367855
   PubMedGoogle Scholar
• LeeSOhSYKimSHPrognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer20131335023876227
   PubMed Web of Science ®Google Scholar
• EoWKJeongDWChangHJAbsolute monocyte and lymphocyte count prognostic score for patients with gastric cancerWorld J Gastroenterol20152192668267625759535
   PubMed Web of Science ®Google Scholar
• JinHZhangGLiuXBlood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapyWorld J Surg Oncol20131111212223705622
   PubMed Web of Science ®Google Scholar
• LeeSMRussellAHellawellGPredictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinomaKorean J Urol2015561174975526568792
   PubMedGoogle Scholar
• JiangCHuWMLiaoFXElevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patientsOnco Targets Ther2016987788326966375
   PubMed Web of Science ®Google Scholar
• KimSHLeeHWGoSILeeSILeeGWClinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancerOncotarget2016724361983620627105529
   PubMedGoogle Scholar
• HoCLLuCSChenJHChenYGHuangTCWuYYNeutrophil/lymphocyte ratio, lymphocyte/monocyte ratio, and absolute lymphocyte count/absolute monocyte count prognostic score in diffuse large B-cell lymphoma: useful prognostic tools in the rituximab eraMedicine (Baltimore)20159424e99326091479
   PubMed Web of Science ®Google Scholar
• ElinavENowarskiRThaissCAHuBJinCFlavellRAInflammation-induced cancer: crosstalk between tumours, immune cells and microorganismsNat Rev Cancer2013131175977124154716
   PubMed Web of Science ®Google Scholar
• JungMRParkYKJeongOElevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancerJ Surg Oncol2011104550451021618251
   PubMed Web of Science ®Google Scholar
• MilneKAlexanderCWebbJRAbsolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytesJ Transl Med2012103322369276
   PubMed Web of Science ®Google Scholar
• KimJWNamKHAhnSHPrognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancerGastric Cancer2016191425225424150
   PubMed Web of Science ®Google Scholar
• MatsumotoYMarusawaHKinoshitaKHelicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epitheliumNat Med200713447047617401375
   PubMed Web of Science ®Google Scholar